2016 Q3 Form 10-Q Financial Statement

#000032001716000143 Filed on August 09, 2016

View on sec.gov

Income Statement

Concept 2016 Q3 2016 Q2 2015 Q2
Revenue $9.317M $8.300M $5.867M
YoY Change 58.23% 41.48% 130596.44%
Cost Of Revenue $8.611M $7.052M $5.799M
YoY Change 79.08% 21.6% 57.69%
Gross Profit $706.3K $1.249M $68.17K
YoY Change -34.59% 1732.11% -101.86%
Gross Profit Margin 7.58% 15.05% 1.16%
Selling, General & Admin $2.769M $2.917M $8.736M
YoY Change -46.2% -66.61% 17.33%
% of Gross Profit 392.05% 233.58% 12816.13%
Research & Development $2.959M $4.489M $7.601M
YoY Change -53.15% -40.95% 31.14%
% of Gross Profit 418.91% 359.41% 11150.18%
Depreciation & Amortization $100.0K -$490.0K $650.0K
YoY Change -84.37% -175.38% 18.18%
% of Gross Profit 14.16% -39.23% 953.54%
Operating Expenses $5.728M $7.406M $31.54M
YoY Change -64.8% -76.52% 86.39%
Operating Profit -$5.728M -$7.406M -$25.67M
YoY Change -44.84% -71.15% 106.5%
Interest Expense $368.4K $335.9K $547.3K
YoY Change -33.39% -38.63% 416.76%
% of Operating Profit
Other Income/Expense, Net -$363.2K -$327.1K $4.808M
YoY Change -62.29% -106.8% -1748.44%
Pretax Income -$6.091M -$7.733M -$20.86M
YoY Change -46.32% -62.93% 63.98%
Income Tax $0.00 $0.00 -$3.703M
% Of Pretax Income
Net Earnings -$7.288M -$7.885M -$17.13K
YoY Change 63961.23% 45939.76% 35.87%
Net Earnings / Revenue -78.21% -94.99% -0.29%
Basic Earnings Per Share
Diluted Earnings Per Share -$1.089M -$1.325M -$3.841M
COMMON SHARES
Basic Shares Outstanding 5.914M shares 59.03M shares 40.15M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2016 Q3 2016 Q2 2015 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $18.60M $17.70M $39.22M
YoY Change -36.72% -54.87% 16.09%
Cash & Equivalents $18.61M $10.34M $36.21M
Short-Term Investments $3.012M
Other Short-Term Assets $7.100M $8.600M $7.000M
YoY Change 5.97% 22.86% 55.56%
Inventory
Prepaid Expenses
Receivables $4.275M $2.892M $1.298M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $29.96M $29.25M $47.47M
YoY Change -22.13% -38.38% 16.2%
LONG-TERM ASSETS
Property, Plant & Equipment $17.12M $17.04M $16.81M
YoY Change 0.17% 1.36% 7.5%
Goodwill $7.013M $7.013M $25.21M
YoY Change -72.18% -72.18% 78.89%
Intangibles $2.450M $2.593M $37.86M
YoY Change -93.5% -93.15% -23.31%
Long-Term Investments
YoY Change
Other Assets $726.8K $812.9K $1.271M
YoY Change -39.92% -36.06% -12.9%
Total Long-Term Assets $27.31M $27.46M $81.15M
YoY Change -66.37% -66.16% -12.31%
TOTAL ASSETS
Total Short-Term Assets $29.96M $29.25M $47.47M
Total Long-Term Assets $27.31M $27.46M $81.15M
Total Assets $57.28M $56.71M $128.6M
YoY Change -52.15% -55.91% -3.58%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $3.246M $2.903M $2.266M
YoY Change 31.57% 28.1% -58.65%
Accrued Expenses $6.373M $6.202M $7.178M
YoY Change -20.45% -13.59% 177.43%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $900.0K
YoY Change -100.0% 350.0%
Long-Term Debt Due $2.320M $5.008M $1.361M
YoY Change -15.69% 267.91% 70.14%
Total Short-Term Liabilities $18.55M $22.36M $16.33M
YoY Change -6.01% 36.9% 37.1%
LONG-TERM LIABILITIES
Long-Term Debt $3.332M $3.644M $13.64M
YoY Change -72.8% -73.29% 249.71%
Other Long-Term Liabilities $370.1K $508.6K $3.467M
YoY Change -89.3% -85.33% 446.02%
Total Long-Term Liabilities $3.702M $4.152M $17.11M
YoY Change -76.43% -75.73% 2593.84%
TOTAL LIABILITIES
Total Short-Term Liabilities $18.55M $22.36M $16.33M
Total Long-Term Liabilities $3.702M $4.152M $17.11M
Total Liabilities $27.89M $31.68M $62.67M
YoY Change -56.9% -49.46% 11.72%
SHAREHOLDERS EQUITY
Retained Earnings -$398.8M -$391.9M -$327.6M
YoY Change 17.67% 19.66% 24.71%
Common Stock $8.182K $5.927K $55.45K
YoY Change -85.26% -89.31% 58.71%
Preferred Stock
YoY Change
Treasury Stock (at cost) $707.6K $707.6K $705.7K
YoY Change 0.27% 0.27% 0.0%
Treasury Stock Shares 11.00K shares 11.00K shares
Shareholders Equity $10.75M $6.050M $66.38M
YoY Change
Total Liabilities & Shareholders Equity $57.28M $56.71M $128.6M
YoY Change -52.15% -55.91% -3.58%

Cashflow Statement

Concept 2016 Q3 2016 Q2 2015 Q2
OPERATING ACTIVITIES
Net Income -$7.288M -$7.885M -$17.13K
YoY Change 63961.23% 45939.76% 35.87%
Depreciation, Depletion And Amortization $100.0K -$490.0K $650.0K
YoY Change -84.37% -175.38% 18.18%
Cash From Operating Activities -$5.710M -$6.550M -$7.590M
YoY Change -34.37% -13.7% -32.59%
INVESTING ACTIVITIES
Capital Expenditures $0.00 -$30.00K -$1.460M
YoY Change -100.0% -97.95% 21.67%
Acquisitions
YoY Change
Other Investing Activities -$610.0K -$640.0K -$3.010M
YoY Change -74.48% -78.74% 245.98%
Cash From Investing Activities -$620.0K -$660.0K -$4.470M
YoY Change -80.32% -85.23% 115.94%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 7.240M -520.0K 29.14M
YoY Change -2435.48% -101.78% 503.31%
NET CHANGE
Cash From Operating Activities -5.710M -6.550M -7.590M
Cash From Investing Activities -620.0K -660.0K -4.470M
Cash From Financing Activities 7.240M -520.0K 29.14M
Net Change In Cash 910.0K -7.730M 17.08M
YoY Change -107.48% -145.26% -300.94%
FREE CASH FLOW
Cash From Operating Activities -$5.710M -$6.550M -$7.590M
Capital Expenditures $0.00 -$30.00K -$1.460M
Free Cash Flow -$5.710M -$6.520M -$6.130M
YoY Change -27.99% 6.36% -39.07%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2015Q4 clbs Aggregate Intrinsic Value Warrants Outstanding
AggregateIntrinsicValueWarrantsOutstanding
0 USD
CY2016Q2 clbs Aggregate Intrinsic Value Warrants Outstanding
AggregateIntrinsicValueWarrantsOutstanding
0 USD
CY2016Q2 clbs Aggregate Intrinsic Value Warrantsvested
AggregateIntrinsicValueWarrantsvested
0 USD
CY2016Q2 clbs Aggregate Intrinsic Value Warrantsvestedandexpectedtovest
AggregateIntrinsicValueWarrantsvestedandexpectedtovest
0 USD
clbs Changein Ownershipin Subsidiary
ChangeinOwnershipinSubsidiary
0 USD
clbs Changein Ownershipin Subsidiary
ChangeinOwnershipinSubsidiary
0 USD
CY2015Q2 clbs Clinical Services Reimbursement
ClinicalServicesReimbursement
900000 USD
clbs Clinical Services Reimbursement
ClinicalServicesReimbursement
1400000 USD
CY2016Q2 clbs Clinical Services Reimbursement
ClinicalServicesReimbursement
2100000 USD
clbs Clinical Services Reimbursement
ClinicalServicesReimbursement
3400000 USD
CY2015Q4 clbs Common Stock Warrants Shares
CommonStockWarrantsShares
321404 shares
CY2016Q2 clbs Common Stock Warrants Shares
CommonStockWarrantsShares
460049 shares
CY2016Q1 clbs Common Stock Warrants Shares
CommonStockWarrantsShares
141844 shares
CY2016Q1 clbs Debt Instrument Maximum Payment To Lender Based On Receipt Of Proceeds From Eligible Events
DebtInstrumentMaximumPaymentToLenderBasedOnReceiptOfProceedsFromEligibleEvents
3000000 USD
clbs Increase Decrease In Accounts Payable Accrued Expenses And Other Liabilities
IncreaseDecreaseInAccountsPayableAccruedExpensesAndOtherLiabilities
2122987 USD
clbs Increase Decrease In Accounts Payable Accrued Expenses And Other Liabilities
IncreaseDecreaseInAccountsPayableAccruedExpensesAndOtherLiabilities
-1253723 USD
CY2015 clbs Interim Efficacy Analysis Followup Milestone Period
InterimEfficacyAnalysisFollowupMilestonePeriod
P6Y
CY2015 clbs Interim Efficacy Analysis Percentage Threshold
InterimEfficacyAnalysisPercentageThreshold
0.50
CY2016Q1 clbs Number Of Consecutive Days Share Price Under One Dollar
NumberOfConsecutiveDaysSharePriceUnderOneDollar
P30D
CY2016Q1 clbs Number Of Consecutive Trading Days Required Above One Dollar
NumberOfConsecutiveTradingDaysRequiredAboveOneDollar
P10D
CY2016Q1 clbs Number Of Days After The Initial Period To Meet Consecutive Trading Day Requirement
NumberOfDaysAfterTheInitialPeriodToMeetConsecutiveTradingDayRequirement
P180D
CY2016Q1 clbs Period In Which To Meet Consecutive Trading Day Threshold
PeriodInWhichToMeetConsecutiveTradingDayThreshold
P180D
CY2015Q4 clbs Preferred Stock Shares Designated
PreferredStockSharesDesignated
825000 shares
CY2016Q2 clbs Preferred Stock Shares Designated
PreferredStockSharesDesignated
825000 shares
clbs Provision For Reduction Of Doubtful Accounts
ProvisionForReductionOfDoubtfulAccounts
2641 USD
clbs Provision For Reduction Of Doubtful Accounts
ProvisionForReductionOfDoubtfulAccounts
0 USD
CY2015 clbs Revene Recognition Period For Cryoperservation Process
ReveneRecognitionPeriodForCryoperservationProcess
PT24H
CY2016Q2 clbs Sharesvestedandexpectedtovest
Sharesvestedandexpectedtovest
460049 shares
CY2016Q1 clbs Subsidiary Ownership Interest By Parent
SubsidiaryOwnershipInterestByParent
0.801
clbs Warrants Canceled
WarrantsCanceled
3200.0 shares
clbs Warrants Exercised
WarrantsExercised
0 shares
clbs Warrants Expired
WarrantsExpired
0 shares
clbs Warrants Granted
WarrantsGranted
141845 shares
clbs Weighted Average Estimated Fair Value Of Restricted Stock
WeightedAverageEstimatedFairValueOfRestrictedStock
31.58
clbs Weighted Average Estimated Fair Value Of Restricted Stock
WeightedAverageEstimatedFairValueOfRestrictedStock
6.05
clbs Weighted Average Exercise Price Warrants Canceled
WeightedAverageExercisePriceWarrantsCanceled
147.50
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
5839963 shares
CY2015Q4 us-gaap Accrued Professional Fees Current And Noncurrent
AccruedProfessionalFeesCurrentAndNoncurrent
480700 USD
CY2016Q2 us-gaap Accrued Professional Fees Current And Noncurrent
AccruedProfessionalFeesCurrentAndNoncurrent
342000 USD
CY2016Q2 clbs Weighted Average Exercise Price Warrants Exercisable
WeightedAverageExercisePriceWarrantsExercisable
98.00
clbs Weighted Average Exercise Price Warrants Exercised
WeightedAverageExercisePriceWarrantsExercised
0.00
clbs Weighted Average Exercise Price Warrants Expired
WeightedAverageExercisePriceWarrantsExpired
0.00
clbs Weighted Average Exercise Price Warrants Granted
WeightedAverageExercisePriceWarrantsGranted
122.60
CY2015Q4 clbs Weighted Average Exercise Price Warrants Outstanding
WeightedAverageExercisePriceWarrantsOutstanding
137.20
CY2016Q2 clbs Weighted Average Exercise Price Warrants Outstanding
WeightedAverageExercisePriceWarrantsOutstanding
98.00
CY2016Q2 clbs Weighted Average Exercise Price Warrantsvestedexpectedtovest
WeightedAverageExercisePriceWarrantsvestedexpectedtovest
98.00
CY2015 clbs Weighted Average Remaining Contractual Termwarrantoutstanding
WeightedAverageRemainingContractualTermwarrantoutstanding
P1Y3M4D
clbs Weighted Average Remaining Contractual Termwarrantoutstanding
WeightedAverageRemainingContractualTermwarrantoutstanding
P1Y0M22D
clbs Weighted Average Remaining Contractual Termwarrantsvested
WeightedAverageRemainingContractualTermwarrantsvested
P1Y0M22D
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--06-30
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2016
dei Document Period End Date
DocumentPeriodEndDate
2016-06-30
dei Document Type
DocumentType
10-Q
dei Entity Central Index Key
EntityCentralIndexKey
0000320017
CY2016Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
5914380 shares
dei Entity Filer Category
EntityFilerCategory
Accelerated Filer
dei Entity Registrant Name
EntityRegistrantName
Caladrius Biosciences, Inc.
CY2015Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
4107388 USD
CY2016Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
2903221 USD
CY2015Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
2566101 USD
CY2016Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
2892467 USD
us-gaap Accretion Expense
AccretionExpense
33054 USD
us-gaap Accretion Expense
AccretionExpense
0 USD
CY2015Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
6198488 USD
CY2016Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
6202343 USD
CY2015Q4 us-gaap Accrued Liabilities Current And Noncurrent
AccruedLiabilitiesCurrentAndNoncurrent
6198400 USD
CY2016Q2 us-gaap Accrued Liabilities Current And Noncurrent
AccruedLiabilitiesCurrentAndNoncurrent
6202400 USD
CY2015Q4 us-gaap Accumulated Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
486 USD
CY2016Q2 us-gaap Accumulated Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
0 USD
CY2015Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
396547401 USD
CY2016Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
398699991 USD
CY2015Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
4416300 USD
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
8132100 USD
CY2016Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
335500 USD
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1235100 USD
CY2015Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
0 USD
CY2016Q2 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
0 USD
CY2015Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
151300 USD
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
302600 USD
CY2016Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
142500 USD
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
285000 USD
CY2015Q4 us-gaap Assets
Assets
57205295 USD
CY2016Q2 us-gaap Assets
Assets
56712900 USD
CY2015Q4 us-gaap Assets Current
AssetsCurrent
29272432 USD
CY2016Q2 us-gaap Assets Current
AssetsCurrent
29253937 USD
CY2016Q2 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
8292000 USD
CY2015Q4 us-gaap Available For Sale Securities Amortized Cost
AvailableForSaleSecuritiesAmortizedCost
6874800 USD
CY2016Q2 us-gaap Available For Sale Securities Amortized Cost
AvailableForSaleSecuritiesAmortizedCost
8292000 USD
CY2015Q4 us-gaap Available For Sale Securities Continuous Unrealized Loss Position Fair Value
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValue
0 USD
CY2016Q2 us-gaap Available For Sale Securities Continuous Unrealized Loss Position Fair Value
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValue
0 USD
CY2015Q4 us-gaap Available For Sale Securities Current
AvailableForSaleSecuritiesCurrent
0 USD
CY2016Q2 us-gaap Available For Sale Securities Current
AvailableForSaleSecuritiesCurrent
0 USD
CY2016Q2 us-gaap Available For Sale Securities Debt Maturities After One Through Five Years Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost
0 USD
CY2016Q2 us-gaap Available For Sale Securities Debt Maturities Remainder Of Fiscal Year Amortized Cost Basis
AvailableForSaleSecuritiesDebtMaturitiesRemainderOfFiscalYearAmortizedCostBasis
8292000 USD
CY2016Q2 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
8292000 USD
CY2016Q2 us-gaap Available For Sale Securities Noncurrent
AvailableForSaleSecuritiesNoncurrent
0 USD
us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
-4800000 USD
us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
0 USD
CY2015Q4 us-gaap Cash
Cash
6875600 USD
CY2016Q2 us-gaap Cash
Cash
8292000 USD
CY2014Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
19174061 USD
CY2015Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
36211324 USD
CY2015Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
20318411 USD
CY2016Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
17699686 USD
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
17037263 USD
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-2618725 USD
CY2016Q1 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
10.00
CY2015Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2016Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2015Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2016Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2015Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000 shares
CY2016Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000 shares
CY2015Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
5673302 shares
CY2016Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
5926749 shares
CY2015Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
5673302 shares
CY2016Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
5926749 shares
CY2015Q4 us-gaap Common Stock Value
CommonStockValue
5673 USD
CY2016Q2 us-gaap Common Stock Value
CommonStockValue
5927 USD
CY2015Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-17124394 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-36312619 USD
CY2016Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-7834716 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-19816119 USD
CY2015Q2 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
-31757 USD
us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
-76349 USD
CY2016Q2 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
-50054 USD
us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
-116933 USD
CY2015Q2 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-17156151 USD
us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-36388968 USD
CY2016Q2 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-7884770 USD
us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-19933052 USD
CY2015Q4 us-gaap Convertible Preferred Stock Shares Issued Upon Conversion
ConvertiblePreferredStockSharesIssuedUponConversion
0.01 shares
CY2016Q2 us-gaap Convertible Preferred Stock Shares Issued Upon Conversion
ConvertiblePreferredStockSharesIssuedUponConversion
0.01 shares
CY2015Q2 us-gaap Cost Of Revenue
CostOfRevenue
5798796 USD
us-gaap Cost Of Revenue
CostOfRevenue
9167408 USD
CY2016Q2 us-gaap Cost Of Revenue
CostOfRevenue
7051546 USD
us-gaap Cost Of Revenue
CostOfRevenue
13279802 USD
CY2015Q4 us-gaap Deferred Costs Current
DeferredCostsCurrent
2911743 USD
CY2016Q2 us-gaap Deferred Costs Current
DeferredCostsCurrent
5149777 USD
CY2015Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
5345225 USD
CY2016Q2 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
7231005 USD
CY2015Q4 us-gaap Deferred Tax Liabilities Noncurrent
DeferredTaxLiabilitiesNoncurrent
932662 USD
CY2016Q2 us-gaap Deferred Tax Liabilities Noncurrent
DeferredTaxLiabilitiesNoncurrent
1032994 USD
CY2015Q4 us-gaap Deferred Tax Liabilities Unrealized Gains On Trading Securities
DeferredTaxLiabilitiesUnrealizedGainsOnTradingSecurities
800 USD
CY2016Q2 us-gaap Deferred Tax Liabilities Unrealized Gains On Trading Securities
DeferredTaxLiabilitiesUnrealizedGainsOnTradingSecurities
0 USD
us-gaap Depreciation And Amortization
DepreciationAndAmortization
1254305 USD
us-gaap Depreciation And Amortization
DepreciationAndAmortization
1422011 USD
CY2015Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-3.84
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-8.83
CY2016Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-1.33
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-3.39
CY2015Q4 us-gaap Employee Related Liabilities Current And Noncurrent
EmployeeRelatedLiabilitiesCurrentAndNoncurrent
2771200 USD
CY2016Q2 us-gaap Employee Related Liabilities Current And Noncurrent
EmployeeRelatedLiabilitiesCurrentAndNoncurrent
3160800 USD
CY2016Q1 us-gaap Equity Method Investment Ownership Percentage
EquityMethodInvestmentOwnershipPercentage
0.199
CY2015Q4 us-gaap Fair Value Estimate Not Practicable Investments
FairValueEstimateNotPracticableInvestments
6875600 USD
CY2016Q2 us-gaap Fair Value Estimate Not Practicable Investments
FairValueEstimateNotPracticableInvestments
8292000 USD
CY2015Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
2822100 USD
CY2016Q2 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
3107100 USD
CY2016Q2 us-gaap Finite Lived Intangible Assets Amortization Expense After Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive
27900 USD
CY2016Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
285000 USD
CY2016Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
570000 USD
CY2016Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
570000 USD
CY2016Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
570000 USD
CY2016Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
570000 USD
CY2015Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
5700000 USD
CY2016Q2 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
5700000 USD
CY2015Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
2877900 USD
CY2016Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
2592900 USD
CY2015Q4 us-gaap Goodwill
Goodwill
7013315 USD
CY2016Q2 us-gaap Goodwill
Goodwill
7013315 USD
CY2016Q2 us-gaap Goodwill Gross
GoodwillGross
7000000 USD
CY2015 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
18200000 USD
CY2015Q2 us-gaap Impairment Of Intangible Assets Indefinitelived Excluding Goodwill
ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill
9400000 USD
us-gaap Impairment Of Intangible Assets Indefinitelived Excluding Goodwill
ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill
9400000 USD
CY2016Q2 us-gaap Impairment Of Intangible Assets Indefinitelived Excluding Goodwill
ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill
0 USD
us-gaap Impairment Of Intangible Assets Indefinitelived Excluding Goodwill
ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill
0 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
406498 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
2238034 USD
us-gaap Impairment Of Long Lived Assets To Be Disposed Of
ImpairmentOfLongLivedAssetsToBeDisposedOf
0 USD
us-gaap Impairment Of Long Lived Assets To Be Disposed Of
ImpairmentOfLongLivedAssetsToBeDisposedOf
591307 USD
CY2015Q2 us-gaap Income Loss From Continuing Operations Attributable To Noncontrolling Entity
IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity
-31757 USD
us-gaap Income Loss From Continuing Operations Attributable To Noncontrolling Entity
IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity
-76349 USD
CY2016Q2 us-gaap Income Loss From Continuing Operations Attributable To Noncontrolling Entity
IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity
-50054 USD
us-gaap Income Loss From Continuing Operations Attributable To Noncontrolling Entity
IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity
-116933 USD
CY2015Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-20861380 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-40046235 USD
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
8005 USD
CY2016Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-7837816 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-19832234 USD
CY2015Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-3703363 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-3656730 USD
CY2016Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
46954 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
100332 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-1816376 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
326366 USD
us-gaap Increase Decrease In Deferred Income Taxes
IncreaseDecreaseInDeferredIncomeTaxes
3656730 USD
us-gaap Increase Decrease In Deferred Income Taxes
IncreaseDecreaseInDeferredIncomeTaxes
-100332 USD
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
308912 USD
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
5698778 USD
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-163393 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-368620 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
35830 USD
CY2015Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
2877880 USD
CY2016Q2 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
2592880 USD
CY2015Q2 us-gaap Interest Expense
InterestExpense
547275 USD
us-gaap Interest Expense
InterestExpense
1098239 USD
CY2016Q2 us-gaap Interest Expense
InterestExpense
359725 USD
us-gaap Interest Expense
InterestExpense
1286542 USD
CY2015Q2 us-gaap Interest Expense Long Term Debt
InterestExpenseLongTermDebt
300000 USD
us-gaap Interest Expense Long Term Debt
InterestExpenseLongTermDebt
600000 USD
CY2016Q2 us-gaap Interest Expense Long Term Debt
InterestExpenseLongTermDebt
200000 USD
us-gaap Interest Expense Long Term Debt
InterestExpenseLongTermDebt
500000 USD
us-gaap Interest Paid
InterestPaid
744811 USD
us-gaap Interest Paid
InterestPaid
1200364 USD
us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
8132106 USD
us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
1235143 USD
CY2015Q1 us-gaap Lease And Rental Expense
LeaseAndRentalExpense
800000 USD
us-gaap Lease And Rental Expense
LeaseAndRentalExpense
1000000 USD
CY2015Q4 us-gaap Liabilities
Liabilities
33921471 USD
CY2016Q2 us-gaap Liabilities
Liabilities
31676272 USD
CY2015Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
57205295 USD
CY2016Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
56712900 USD
CY2015Q4 us-gaap Liabilities Current
LiabilitiesCurrent
21015223 USD
CY2016Q2 us-gaap Liabilities Current
LiabilitiesCurrent
22356813 USD
CY2016Q2 us-gaap Long Term Debt
LongTermDebt
10200000 USD
CY2015Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
4171456 USD
CY2016Q2 us-gaap Long Term Debt Current
LongTermDebtCurrent
5007851 USD
CY2016Q2 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Five
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive
3000000 USD
CY2016Q2 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Four
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour
6800000 USD
CY2016Q2 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Three
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
400000 USD
us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
537 USD
CY2015Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
10828544 USD
CY2016Q2 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
3643502 USD
CY2015Q4 us-gaap Long Term Notes Payable
LongTermNotesPayable
583041 USD
CY2016Q2 us-gaap Long Term Notes Payable
LongTermNotesPayable
321375 USD
CY2015Q4 us-gaap Marketable Securities Restricted Current
MarketableSecuritiesRestrictedCurrent
6875600 USD
CY2016Q2 us-gaap Marketable Securities Restricted Current
MarketableSecuritiesRestrictedCurrent
8292000 USD
CY2015Q4 us-gaap Minority Interest
MinorityInterest
-429709 USD
CY2016Q2 us-gaap Minority Interest
MinorityInterest
-413630 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
36631046 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
13660127 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
2233236 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-1703297 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-21827019 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-14575555 USD
CY2015Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-17126260 USD
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-36313156 USD
CY2016Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-7834716 USD
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-19815633 USD
CY2015Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
4807570 USD
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
3710579 USD
CY2016Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-352865 USD
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-1273997 USD
CY2015Q4 us-gaap Notes Payable
NotesPayable
1800000 USD
CY2016Q2 us-gaap Notes Payable
NotesPayable
1300000 USD
CY2015Q4 us-gaap Notes Payable Current
NotesPayableCurrent
1192666 USD
CY2016Q2 us-gaap Notes Payable Current
NotesPayableCurrent
1012393 USD
CY2015Q2 us-gaap Operating Expenses
OperatingExpenses
31535913 USD
us-gaap Operating Expenses
OperatingExpenses
52796056 USD
CY2016Q2 us-gaap Operating Expenses
OperatingExpenses
15785390 USD
us-gaap Operating Expenses
OperatingExpenses
34348155 USD
CY2015Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-25668950 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-43756814 USD
CY2016Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-7484951 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-18558237 USD
CY2016Q2 us-gaap Operating Leases Future Minimum Payments Due
OperatingLeasesFutureMinimumPaymentsDue
5896000 USD
CY2016Q2 us-gaap Operating Leases Future Minimum Payments Due In Five Years
OperatingLeasesFutureMinimumPaymentsDueInFiveYears
960200 USD
CY2016Q2 us-gaap Operating Leases Future Minimum Payments Due In Four Years
OperatingLeasesFutureMinimumPaymentsDueInFourYears
990100 USD
CY2016Q2 us-gaap Operating Leases Future Minimum Payments Due In Three Years
OperatingLeasesFutureMinimumPaymentsDueInThreeYears
1037100 USD
CY2016Q2 us-gaap Operating Leases Future Minimum Payments Due In Two Years
OperatingLeasesFutureMinimumPaymentsDueInTwoYears
1866900 USD
CY2016Q2 us-gaap Operating Leases Future Minimum Payments Remainder Of Fiscal Year
OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear
1041700 USD
CY2015Q4 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
221500000 USD
CY2015Q4 us-gaap Other Accrued Liabilities Current And Noncurrent
OtherAccruedLiabilitiesCurrentAndNoncurrent
2946500 USD
CY2016Q2 us-gaap Other Accrued Liabilities Current And Noncurrent
OtherAccruedLiabilitiesCurrentAndNoncurrent
2699600 USD
CY2015Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
976768 USD
CY2016Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
812888 USD
us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
-486 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
4808818 USD
CY2015Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
1866 USD
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
537 USD
CY2016Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
0 USD
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-486 USD
CY2015Q2 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
1866 USD
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
537 USD
CY2016Q2 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
0 USD
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-486 USD
CY2015Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
562001 USD
CY2016Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
508590 USD
CY2015Q4 us-gaap Other Long Term Debt Noncurrent
OtherLongTermDebtNoncurrent
0 USD
CY2016Q2 us-gaap Other Long Term Debt Noncurrent
OtherLongTermDebtNoncurrent
3812998 USD
CY2015Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
5354845 USD
CY2016Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
6860 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
12545 USD
CY2016Q1 us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
100000 USD
us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
3013157 USD
us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
0 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1802607 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1703297 USD
CY2015Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2016Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2015Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
20000000 shares
CY2016Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
20000000 shares
CY2015Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
10000 shares
CY2016Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
10000 shares
CY2015Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
10000 shares
CY2016Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
10000 shares
CY2015Q4 us-gaap Preferred Stock Value
PreferredStockValue
100 USD
CY2016Q2 us-gaap Preferred Stock Value
PreferredStockValue
100 USD
CY2015Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
3476177 USD
CY2016Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
3512007 USD
us-gaap Proceeds From Divestiture Of Interest In Consolidated Subsidiaries
ProceedsFromDivestitureOfInterestInConsolidatedSubsidiaries
0 USD
us-gaap Proceeds From Divestiture Of Interest In Consolidated Subsidiaries
ProceedsFromDivestitureOfInterestInConsolidatedSubsidiaries
19400000 USD
CY2016Q1 us-gaap Proceeds From Issuance Of Warrants
ProceedsFromIssuanceOfWarrants
1000000 USD
us-gaap Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
36136414 USD
us-gaap Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
1050712 USD
us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
1089611 USD
us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
368615 USD
us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
7049000 USD
us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
0 USD
CY2015Q2 us-gaap Profit Loss
ProfitLoss
-17158017 USD
us-gaap Profit Loss
ProfitLoss
-36389505 USD
CY2016Q2 us-gaap Profit Loss
ProfitLoss
-7884770 USD
us-gaap Profit Loss
ProfitLoss
-19932566 USD
CY2015Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
17064900 USD
CY2016Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
17039880 USD
CY2015Q4 us-gaap Redeemable Noncontrolling Interest Equity Carrying Amount
RedeemableNoncontrollingInterestEquityCarryingAmount
0 USD
CY2016Q2 us-gaap Redeemable Noncontrolling Interest Equity Carrying Amount
RedeemableNoncontrollingInterestEquityCarryingAmount
19400000 USD
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
0 USD
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
6348646 USD
us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
594979 USD
us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
810554 USD
CY2015Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
7600744 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
14404376 USD
CY2016Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
4027965 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
9904143 USD
CY2015Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-372132490 USD
CY2016Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-391948123 USD
CY2015Q2 us-gaap Revenues
Revenues
5866963 USD
us-gaap Revenues
Revenues
9039242 USD
CY2016Q2 us-gaap Revenues
Revenues
8300439 USD
us-gaap Revenues
Revenues
15789918 USD
CY2015Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
8736373 USD
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
19824272 USD
CY2016Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
4705879 USD
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
11164210 USD
CY2016Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
460300 shares
CY2015Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
100 USD
CY2016Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
18900 USD
CY2016Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue
18400 USD
CY2016Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
9000 USD
CY2016Q1 us-gaap Share Price
SharePrice
1.00
CY2016Q1 us-gaap Share Price
SharePrice
7.05
us-gaap Stock Issued During Period Shares Restricted Stock Award Gross
StockIssuedDuringPeriodSharesRestrictedStockAwardGross
127606 shares
us-gaap Stock Issued During Period Shares Restricted Stock Award Gross
StockIssuedDuringPeriodSharesRestrictedStockAwardGross
107719 shares
us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
36136414 USD
us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
1050712 USD
us-gaap Stock Issued During Period Value Restricted Stock Award Gross
StockIssuedDuringPeriodValueRestrictedStockAwardGross
4029500 USD
us-gaap Stock Issued During Period Value Restricted Stock Award Gross
StockIssuedDuringPeriodValueRestrictedStockAwardGross
651700 USD
us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
8132106 USD
us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
1235144 USD
CY2015Q4 us-gaap Stockholders Equity
StockholdersEquity
23713533 USD
CY2016Q2 us-gaap Stockholders Equity
StockholdersEquity
6050258 USD
CY2014Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
58073789 USD
CY2015Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
65953341 USD
CY2015Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
23283824 USD
CY2016Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
5636628 USD
CY2015Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
10999 shares
CY2016Q2 us-gaap Treasury Stock Shares
TreasuryStockShares
10999 shares
CY2015Q4 us-gaap Treasury Stock Value
TreasuryStockValue
707637 USD
CY2016Q2 us-gaap Treasury Stock Value
TreasuryStockValue
707637 USD
CY2015Q2 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
4457480 shares
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
4110413 shares
CY2016Q2 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
5907013 shares

Files In Submission

Name View Source Status
0000320017-16-000143-index-headers.html Edgar Link pending
0000320017-16-000143-index.html Edgar Link pending
0000320017-16-000143.txt Edgar Link pending
0000320017-16-000143-xbrl.zip Edgar Link pending
clbs-10qx20160630.htm Edgar Link pending
clbs-20160630.xml Edgar Link completed
clbs-20160630.xsd Edgar Link pending
clbs-20160630_cal.xml Edgar Link unprocessable
clbs-20160630_def.xml Edgar Link unprocessable
clbs-20160630_lab.xml Edgar Link unprocessable
clbs-20160630_pre.xml Edgar Link unprocessable
clbs-ex311_20160630xq2.htm Edgar Link pending
clbs-ex312_20160630xq2.htm Edgar Link pending
clbs-ex321_20160630xq2.htm Edgar Link pending
clbs-ex322_20160630xq2.htm Edgar Link pending
exhibit101djmamendment.htm Edgar Link pending
exhibit102jtamendment.htm Edgar Link pending
exhibit103rpamendment.htm Edgar Link pending
exhibit104dwlamendment.htm Edgar Link pending
exhibit31arcertofincorpeff.htm Edgar Link pending
exhibit32arbylawseff072720.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending